.Bayer put on hold the period 3 trial for its variable XIa inhibitor asundexian late in 2013 after t...
.Sanofi is actually still bented on taking its own a number of sclerosis (MS) med tolebrutinib to th...
.Galapagos is actually coming under additional pressure from clients. Having actually developed a 9....
.Welcome to this week's Chutes & Ladders, our roundup of substantial management hirings, shooting...
.Shanghai Allist Pharmaceuticals has acquired on its own a starring character in China's KRAS market...
.ReNeuron has actually participated in the long listing of biotechs to leave behind Greater london's...
.MBX Biosciences has added to the recent spurt of IPO filings. The biotech, which submitted its own ...
.For Lykos Therapeutics as well as the provider's prospective MDMA-assisted therapy for post-traumat...
.Merely times after gene publisher Tome Biosciences announced undisclosed operational slices, a more...
.Repare Therapy is actually laying off a quarter of its workforce as the oncology biotech lessen its...